In recent decades, the scientific community has turned its focus toward microalgae as a source of unique bioactive compounds, with chlorella—a single-celled green algae—emerging as a particularly promising subject for biotechnological and medical research. Among its many derivatives, the chlorella peptide IPH C stands out for its broad spectrum of potential health benefits.
Research indicates that chlorella peptide IPH C possesses significant antioxidant properties, enabling it to effectively protect cellular structures from damage caused by free radicals. A study conducted in 2017 revealed that supplementing diets with chlorella peptide IPH C led to a notable 30% reduction in oxidative stress markers among participants.
Chlorella peptide IPH C is shown to bolster the immune system. In a clinical trial where participants consumed IPH C supplements daily for 8 weeks, there was a remarkable 58% increase in natural killer cell activity, signaling a significant boost in immune function.
Chlorella-based peptides, like IPH C, also play a crucial role in reducing inflammation. Research published in the “Journal of Medicinal Food” demonstrates that intake of chlorella peptide IPH C results in a 22% decrease in inflammatory cytokines, making it a powerful agent against chronic inflammation.
The ability of chlorella peptide IPH C to regulate gut microbiota warrants attention. Evidence suggests that regular consumption of IPH C improves intestinal flora, increasing the population of beneficial bacteria such as Lactobacillus and Bifidobacterium by 10-15%.
Studies confirm that chlorella peptide IPH C possesses numerous beneficial properties, including antioxidant activity, immune response enhancement, anti-inflammatory effects, and a positive impact on gut microbiota. These findings underscore the significance of chlorella peptide IPH C in healthcare and biotechnology fields.